Table 2. Average Direct Medical Costs of HCV Treatment in Both Types of Combination Therapy (Costs are Expressed in PPP$).

Genotype	No.	Hospitalization, No.a	Confirmatory Tests, No.b	Physician Visit, No.c	Laboratory Testsd	Medicatione	Total cost
Interferon + Ribavirin
1	133	60	120	388	2,036	2,128	4,732
2	2	28	53	530	2,551	1,492	4,655
3	48	34	79	297	1,796	1,276	3,482
Total	183	53	108	365	1,979	1,898f	4,403g
Peg + Ribavirin
1	149	43	83	422	2,384	18,582	21,515
2	3	41	121	464	2,435	14,838	17,899
3	30	27	68	311	2,013	10,327	12,745
Total	182	40	81	405	2,324	17,160f	20,010g
Total
	365	46	95	385	2,151	9,508	12,185

^aShort term of hospitalization due to liver biopsy

^bConfirmatory tests include; Endoscopy, Sonography, liver biopsy, Pathology and Electrophorus

^cPhysician visit include; Costs of routine visits by a gastroenterologist

^dLaboratory tests include; CBC, PT, FBS, TG, Chol, BUN, Cr, Bil.T, Bil.D, AST, ALT, ALP, T3, T4, TSH, Anti-TPO(ELISA), Anti-Thyroglobulin, T3Ru, HBsAg, HBsAb, HAVAb, HBcAb, Anti-HCV (ELISA), Anti-HCV (RIBA), Anti-HIV (ELISA), Genotype, PCR, Viral load

^eMedication include; Costs of (INF-RBV) and (PEG-RBV)

^fStatistical significant among medication costs of HCV treatment in both types of therapy was P<0.001

^gStatistical significant among direct medical costs of HCV treatment in both types of therapy P<0.001